Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing long COVID ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...

How long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Center ...

In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in ...

Several illnesses - including COVID-19 - are currently circulating statewide.

Researchers at Northwestern University used a smartphone app to follow patients with neurological symptoms stemming from long ...

Another deadly virus is threatening the world, bringing back memories of the coronavirus and how ill-prepared the health systems of many countries, including the Philippines, were in dealing with it ...

Long COVID affects people differently from varied geographical locations. Patients in the U.S. reported much more brain fog symptoms than those in India or Nigeria.

Eyam Health and iiDiagnostics (iiDX), a company formed by the Infection Innovation Consortium: iiCON, have launched a ...

Two little-known animal viruses, influenza D and canine coronavirus, show signs of adapting to humans, according to experts.

The mpox virus appears to be circulating silently in parts of Nigeria, in many cases without the symptoms typically ...

By Hugo Francisco de Souza A new perspective highlights how the influenza D virus and a canine–feline recombinant coronavirus ...